Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Mutations in the p53 tumor suppressor are the most frequently observed genetic alterations in human cancer. The majority of the mutations occur in the core domain which contains the sequence-specific DNA binding activity of the p53 protein (residues 102-292), and they result in loss of DNA binding. The crystal structure of a complex containing the core domain of human p53 and a DNA binding site has been determined at 2.2 angstroms resolution and refined to a crystallographic R factor of 20.5 percent. The core domain structure consists of a beta sandwich that serves as a scaffold for two large loops and a loop-sheet-helix motif. The two loops, which are held together in part by a tetrahedrally coordinated zinc atom, and the loop-sheet-helix motif form the DNA binding surface of p53. Residues from the loop-sheet-helix motif interact in the major groove of the DNA, while an arginine from one of the two large loops interacts in the minor groove. The loops and the loop-sheet-helix motif consist of the conserved regions of the core domain and contain the majority of the p53 mutations identified in tumors. The structure supports the hypothesis that DNA binding is critical for the biological activity of p53, and provides a framework for understanding how mutations inactivate it.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Modification of any of five arginine residues that are hotspots for TP53 mutations in human cancers disables TP53 sequence-specific DNA binding (Cho, et al., 1994).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Cho, et al., 1994
In the citing paper
“Gly-245 in the wild type adopts unusual backbone dihedral angles (1), which are not favored when the residue is replaced by serine.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The crystal structure of p53 core domain shows that the epitope of PAb240, located in strand 7, is inaccessible to antibody binding (1), and at least a partly unfolded form is required to expose the epitope.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The guanidinium group of Arg-249 is salt-bridged to the carboxylate group of Glu-171 in L2 and backbone oxygens of Gly-245 and Met-246 (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“suggesting the structure of p53 core domain in solution is similar to that in crystal structure (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Principles of Nucleic Acid Structure
Saenger, W. (1984) · Springer Advanced Texts in Chemistry · doi:10.1007/978-1-4612-5190-3 · Cited by 4,150
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Research works printed but not linked: 2
- SACK, J. S., JOURNAL OF MOLECULAR GRAPHICS 6: 224 (1988).
- TONRUD, D.E., ACTA CRYSTALLOGR A 43: 489 (1987).
Cited by
Items 2,201–2,300 of 2,517
Molecular evolution of the p53 network in reptiles
Parsai, S. (2013) · Iowa State University Digital Repository (Iowa State University) · Cited by 1
Improving Stability of Tumor Suppressor Protein, p53
Heberling, M. M. (2007) · The Knowledge Bank (The Ohio State University)
Novel Roles of Replication Protein A Phosphorylation in the Cellular Response to DNA Damage
Serrano, M. A. (2013) · Digital Commons - East Tennessee State University (East Tennessee State University)
Hussain, S. P., & Harris, C. C. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1305-6_18
Tumour suppressor proteins in proliferating and differentiating cells
Bodalina, U. M. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Alshatwi, A. A. (2003) · UA Campus Repository (The University of Arizona)
Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation
Latonen, L. (2003) · Helda - University of Helsinki Institutional Repository
The Role of Structure in Complexes Between the p53 DNA Binding Domain and DNA Response Elements
Nagaich, A. K., Balagurumoorthy, P., Miller, W. M., et al. (1997) · Springer eBooks · doi:10.1007/978-94-011-5550-2_9
“However, allosterism associated with DNA binding in the p53DBD alone appears inconsistent with the cocrystal study [ 38 ] since this work reported the same structure for both bound and unbound p53DBD peptides.”
BackgroundMethodResultInfluentialA TATA-kötő fehérje asszociált faktor 3 (TAF3) p53-mal való kölcsönhatásának funkcionális vizsgálata
Buzás-Bereczki, O. (2010) · SZTE Repository of Dissertations (University of Szeged)
Structural Basis for the Pharmacological Rescue of Mutant p53 With Small Molecule Compounds
Ho, W. C. (2003) · Defense Technical Information Center (DTIC)
Genetic alterations during neoplastic progression in Barrett's esophagus
Bian, Y. (2002) · RePub (Erasmus University Rotterdam)
Bioinformatics Approaches to the Functional Profiling of Genetic Variants
Li, B., Radivojac, P., & Mooney, S. D. (2012) · InTech eBooks · doi:10.5772/45900
“Six mutation hot spots, such as R175H, R273H, and R282W, have been mapped to the p53 DNA-binding core domain that is critical to its activation, and most of them destabilize protein structure, leading to the degradation of p53 [10].”
BackgroundCornell, R. M., & Schwertmann, P. E. D. D. H. C. U. (2003) · doi:10.1002/3527602097.source
Structure-Based Design of Molecules to Reactivate Tumor Derived p53 Mutations
Marmorstein, R. (2005) · doi:10.21236/ada437665
Structural and functional interrogation of Anterior Gradient-2
Gray, T. A. (2013) · ERA
Small Molecules as Research Tools for Studying the Biology of the Tumour Suppressor p53
Spinnler, C. (2011) · Figshare
Regulation of the p53 Tumor‐Suppressor Protein by Ubiquitin and Ubiquitin‐Like Molecules
Xirodimas, D. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch2c
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
Influence of genetic polymorphisms on DNA repair, p53 mutations and cancer risk
Ryk, C. (2006) · Figshare
Touqan, N. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
Sarek, G. (2010) · Helda - University of Helsinki Institutional Repository
Biophysical and Biochemical Properties of the p53 Protein
Mukhopadhyay, T. K., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_4
Maroni, G. (2000) · doi:10.1002/9780470760079.ch8
One Carbon Metabolism and Methylation in Breast Tumors
Sumner, S. B., & Shields, P. G. (2004) · Defense Technical Information Center (DTIC) · doi:10.21236/ada428992
The Molecular Pathogenesis of Aflatoxin with Hepatitis B Virus-Infection in Hepatocellular Carcinoma
Cao, H., & Jiangao, F. (2011) · InTech eBooks · doi:10.5772/22593 · Cited by 1
Puray‐Chavez, M., & Palomino, Y. R. (2014) · Anales de la Facultad de Medicina · doi:10.15381/anales.v60i1.4500
Pinezi, J. C. D. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-09012015-163553
Wang, H., Lai, B., Li, J., et al. (2002) · PubMed · doi:10.3779/j.issn.1009-3419.2002.01.01
Involvement of p53 in the S-phase Checkpoint during Nucleotide Deficiencies
Heyer, C. L. (2011) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/4zf5-2439
“The DNA binding domain contains the majority of mutation hotspots in human cancer; the most frequently occurring mutations are in the peptides that make the closest contacts with DNA, explaining why many p53 mutants are unable to bind DNA (Cho et al., 1994).”
BackgroundCHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
Wasielewski, M. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Harrington, R. E., Zhurkin, V. B., Durell, S. R., Jernigan, R. L., Nagaich, A. K., & Appella, E. (2000) · Springer eBooks · doi:10.1007/978-3-642-59631-5_19
Lindahl, T. (2004) · Figshare · Cited by 1
Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression
Li, H. (2014) · Figshare
Spy1 Regulation of the DNA Damage Response; Checkpoint Activation and Cellular Senescence
Jalili, E. (2013) · Scholarship at UWindsor (University of Windsor)
hMOF and associated proteins in transcription and cancer
Classen, S. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16867
Mechanistic studies of APR-246 in leukemia
Ali, D. (2013) · Figshare
Prognostic Significance of iNOS in Esophageal Cancer
Matsumoto, M., Ohtsuki, Y., & Furihata, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_18
“cancers (El-Deiry et al. 1992; Cho et al. 1994).”
Einfluss DNA-bindender Proteine auf die Hybridisierungsdynamik diagnostischer DNA-Mikroarrays
Schulz, G. (2002) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1719
TP53: A master gene in normal and tumor suppression
Hainaut, P. L. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.017
Studies of mutant p53-targeting small molecules
Zache, N. (2007) · Figshare
Martín, E. G. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Iwamoto, K. S. (2002) · International Congress Series · doi:10.1016/s0531-5131(01)00777-4
Yun, H. Y., & Huh, S. H. (2013) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2013.34.4.1300
Weak Distance Dependence of Excess Electron Transfer in DNA
Behrens, C., Burgdorf, L. T., Schwögler, A., & Carell, T. (2002) · Angewandte Chemie · doi:10.1002/1521-3757(20020517)114:10<1794::aid-ange1794>3.0.co;2-c · Cited by 39
The molecular genetic basis of childhood neoplasia
Mott, M. G. (1995) · Clinical Oncology · doi:10.1016/s0936-6555(05)80534-5
Review : p53 in the pathogenesis, diagnosis, and treatment of cancer
Perz, E., & Kuhn, J. G. (1998) · Journal of Oncology Pharmacy Practice · doi:10.1177/107815529800400201 · Cited by 1
Regulation of Phenotypic Plasticity in Triple-Negative Breast Cancer
D’Amato, N. C. (2011) · DukeSpace (Duke University)
Biochemie und Molekulargenetik 1994
Schomburg, D., & Niefind, K. (1995) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19950430210
Lüleyap, H. Ü., İzmirli, M., Onatoğlu, D., et al. (2010) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2009-16585
Small molecules that affect the p53 pathway and their potential use in the treatment of cancer
Sachweh, M. C. C. (2014) · Figshare
Oncogenic Mutations and Packing Defects in Protein Structure
Fernández, A. (2003) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2003.10506901
Watanabe, T., Tsushima, K., & Munakata, A. (2005) · Institutional Repositories DataBase (IRDB) · doi:10.32216/hirosakiigaku.56.2-4_69
Significance of genetic instability in development and chemosensitivity of malignant tumors
Olasz, J. (2009) · Clinical and Experimental Medical Journal · doi:10.1556/cemed.3.2009.1.17
Hernández, I., Maddison, L. A., Wei, Y., DeMayo, F. J., Petras, T., Li, B., Gingrich, J. R., Rosen, J. M., & Greenberg, N. M. (2003) · PubMed · Cited by 34
Basics of Nucleic Acid Structure
Schneider, B., & Berman, H. M. (2006) · Springer eBooks · doi:10.1007/978-1-4020-4851-3_1
Dysregulation des Zellzyklus (p53, Zykline)
Kalthoff, H., Röder, C., Schmiegel, W., Naumann, M., & Kremer, B. (1995) · Springer eBooks · doi:10.1007/978-3-642-79782-8_2
Buettner, G. R., Oberley, L. W., Spitz, D. R., & Domann, F. E. (2003)
Li-Fraumeni syndrome, clinical and molecular genetics
Ruijs, M. (2010) · Pure Amsterdam UMC · Cited by 1
Diseño de un sistema de producción recombinante de péptidos con potencial terapéutico
Gallardo, V. R. (2013) · Universidad de Chile
Head and Neck Cancer : Factors Affecting Tumour Growth
Sundelin, K. (2007) · DiVA (Digitala Vetenskapliga Arkivet)
Pharmacological targeting of mutant p53 family members
Rökaeus, N. (2011) · Figshare
Jeffy, B. D. (2003) · UA Campus Repository (The University of Arizona)
Zerati, M. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-23082011-143257
“A maioria das mutações do p53 ocorre em sítios que codificam sequências de domínios específicos de ligação com DNA, causando perda da capacidade de ligação entre a proteína p53 e o DNA.(127)”
Pusiol, T. (2012) · Journal of Public Health and Epidemiology · doi:10.5897/jphe12.011
“Mutant p53 proteins are devoid of these functions, because they lose the ability of DNA contact or destabilize the structure of the core domain (Cho et al., 1994).”
BackgroundPinto, E. M. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2005.tde-07102014-094643 · Cited by 1
Functions of the coregulator protein SNURF (RNF4) in transcription and cell growth
Häkli, M. (2005) · Helda - University of Helsinki Institutional Repository
Crosstalk Between Iron Homeostasis And Nitric Oxide Signalling: Impact On Cancer Cell Viability
Ariffin, M. (2012) · Otago University Research Archive (University of Otago)
Specific mutation screening of TP53 gene by low-density DNA microarray
Rangel, A., Tenorio, A. M., Beattie, K. L., et al. (2009) · Nanotechnology Science and Applications · doi:10.2147/nsa.s4469
“This tumor suppressor gene is mapped on the short arm of chromosome 17 and harbors tumor-causing DNA missense mutations in the region that encodes the DNA-binding domain (DBD) (exons 5–8).3 Mutations in this region lead to nuclear accumulation of p53 protein and loss of its normal cellular functions, such as transcrip…”
BackgroundZambetti, G. P., & Ribeiro, R. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_12
“They are selected during tumorigenesis for their ability to abrogate TP53 DNA binding and transcriptional regulation [20].”
BackgroundMechanism of benzo(a)pyrene-induced accumulation of p53 tumour suppressor protein in mouse
Serpi, R. (2003) · Cited by 2
gZhang, Y., & nOu-Yang, Z.-C. (2001)
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
Deppert, W. (2000)
Mutagenesis of the p̳53 tumor suppressor gene studied in Saccharomyces cerevisiae
Moshinsky, D. J. (1998) · DSpace@MIT (Massachusetts Institute of Technology)
DELETIONS IN THE DNA–BINDING DOMAIN OF THE TP53 GENE IN v-src–TRANSFORMED CHICKEN CELLS
Plachý, J., & Trtková, K. (2003) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0312091.1
“The incidence of spontaneous tumors increases dramatically in p53-deficient mice, and inactivation of the p53 protein due to mutations of critical residues is common in human tumors and immortal cell lines (Levine et al., 1991, 1994; Cho et al., 1994).”
BackgroundHuman Pathogenic Mutations in Protein Domains
Lappalainen, I. (2004) · Työväentutkimus Vuosikirja
der Naturwissenschaften, D. (2008)
Alver, B. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Intrinsically disordered proteins in molecular recognition and structural proteomics
Oldfield, C. J. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/934
Hosako, H. (2009) · OakTrust (Texas A&M University Libraries)
Fanucchi, S. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
NAPPA-Based Vaccines for a New Proteogenomics Approach for Public Health
Bragazzi, N. L., Pechkova, E., & Nicolini, C. A. (2015) · NanoWorld Journal · doi:10.17756/nwj.2015-003
“)[54] – is an important oncogene, whose mutations are frequently detected in human cancer (data analyzed from the database www.”
BackgroundStatistical Conservation Analysis of Zinc-interacting Residues
Kasampalidis, I. N., Lyroudia, K., & Pitas, I. (2006)
Chen, E. I.-T., Wu, J., Su, W.-H., Wang, T., & Au, L. (2009) · doi:10.6136/jms.2009.29(4).179
Modeling p53 transcriptional regulation
Riley, T. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t31836rn
Oncogenes en oftalmología. Su importancia en la interpretación de las neoplasias. Revisión del tema
González-Almaraz, G., & Pineda-Cárdenas, M. A. A. (2004) · Revista Mexicana de Oftalmología
Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)
Mutations of Bovine p53 Gene in Bovine Leukemia Virus-Induced B-Cell Lymphosarcoma.
Tajima, S., & Aida, Y. (1999) · Dōbutsu Iden Kenkyūkaishi/Dobutsu iden kenkyukaishi · doi:10.5924/abgri1993.27.45
Molecular and functional analysis of the tumour antigen T21
Alshehri, B. M. (2015) · Nottingham Trent University's Institutional Repository (Nottingham Trent Repository)
Characteristics of p53 mutational spectrum in oral squamous cell carcinoma.
Yamazaki, Y., Chiba, I., HIRAI, A., Satoh, C., Sakakibara, N., NOTANI, K.-I., Fukuda, H., Kashiwazaki, H., Tei, K., & Totsuka, Y. (2001) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.47.389 · Cited by 1
Yamazaki, Y., Chiba, I., HIRAI, A., et al. (2001) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.47.649
Sex-specific effects of drosophila p53 on adult life span
Shen, J. (2009) · University of Southern California Digital Library · doi:10.25549/usctheses-m2329
Gauch, H. G. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511815034.013
Metadata
- Authors
- Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- Science
- Published
- 1994-07-15
- Volume
- 265
- Issue
- 5170
- Pages
- 346-355
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096276671
- Semantic Scholar
- 11096f3b08e172ce5e261795b6749818ee59c03d
- Cited by
- 2,551
- References
- 62
- Citations by year
- 2026: 62 · 2025: 52 · 2024: 40 · 2023: 64 · 2022: 61 · 2021: 73 · 2020: 67 · 2019: 62 · 2018: 61 · 2017: 54 · 2016: 64 · 2015: 62 · 2014: 81 · 2013: 78 · 2012: 68
- FWCI
- 64.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- National Cancer Institute (NCI CA08748-29)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- p53 tumor suppressor, p53 core domain, DNA binding, zinc coordination, beta-sandwich, cancer genetics
- MeSH terms
- Amino Acid Sequence, Base Sequence, Binding Sites, Computer Graphics, Crystallization, DNA, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Protein Conformation, Genes, p53, Tumor Suppressor Protein p53, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.